Literature DB >> 6120740

Jogger's blockade.

A Breckenridge.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6120740      PMCID: PMC1496175          DOI: 10.1136/bmj.284.6315.532

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Beta-blockers and running.

Authors:  L Kaijser; P Kaiser; J Karlsson; S Rössner
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

2.  Propranolol and marathon running.

Authors:  A J Williams
Journal:  Am Heart J       Date:  1979-10       Impact factor: 4.749

3.  The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man.

Authors:  S B Pearson; D C Banks; J M Patrick
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

4.  Limitation of work performance in normal adult males in the presence of beta-adrenergic blockade.

Authors:  S D Anderson; P T Bye; C P Perry; G P Hamor; G Theobald; G Nyberg
Journal:  Aust N Z J Med       Date:  1979-10
  4 in total
  5 in total

1.  Impairment of physical performance after treatment with beta blockers and alpha blockers.

Authors:  C Bengtsson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

Review 2.  Which beta blocker?

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

3.  Should every survivor of a heart attack be given a beta blocker? Part II. Evidence from a clinical pharmacological standpoint.

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

4.  Influence of beta adrenergic blockade on effects of physical training in patients with ischaemic heart disease.

Authors:  L Vanhees; R Fagard; A Amery
Journal:  Br Heart J       Date:  1982-07

5.  The effect of a week's beta-adrenoceptor antagonism on daytime heart-rates, subjective responses to exercise, and physical activity in normal subjects.

Authors:  J M Patrick; H J Wharrad; C G Wilson; A T Birmingham
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.